摘要
Objective We investigated the impact of MYC/BCL-2 protein co-expression on the prognosis of diffuse large B-cell lymphoma (DLBCL) patients and observed whether double expression (DE) remains an independent poor prognostic factor in DLBCL after the addition of therapeutic factors such as DA-EPOCH-, central prophylaxis, and transplantation.Methods Available pathological findings were retrospectively collected from 223 DLBCL patients at the Peking Union Medical College Hospital from 2015 to 2018.
作者
ZHAN Jing
詹景(Dept Hematol,CAMS&PUMC,Beijing 100730)
